Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Vanessa Da Silva Silveira, Ph.D.

Concepts (194)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Vanessa Da Silva Silveira's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Vanessa Da Silva Silveira has written about over time.
DNA Repair Enzymes, 1 publications between 2009 and 2009, average publication date January 2009. Thymidylate Synthase, 3 publications between 2006 and 2011, average publication date January 2009. Xeroderma Pigmentosum Group D Protein, 3 publications between 2006 and 2011, average publication date January 2009. Cytochrome P-450 CYP2D6, 3 publications between 2009 and 2010, average publication date May 2009. Epoxide Hydrolases, 3 publications between 2009 and 2010, average publication date May 2009. NAD(P)H Dehydrogenase (Quinone), 4 publications between 2009 and 2010, average publication date October 2009. Polymorphism, Genetic, 6 publications between 2006 and 2012, average publication date February 2010. Precursor Cell Lymphoblastic Leukemia-Lymphoma, 12 publications between 2009 and 2014, average publication date March 2011. Gene Expression Regulation, Leukemic, 2 publications between 2012 and 2014, average publication date May 2013. NF-kappa B, 3 publications between 2012 and 2024, average publication date December 2016. Adrenal Cortex Neoplasms, 1 publications between 2017 and 2017, average publication date June 2017. Adrenocortical Carcinoma, 1 publications between 2017 and 2017, average publication date June 2017. Phthalazines, 1 publications between 2017 and 2017, average publication date June 2017. Protein Kinase Inhibitors, 4 publications between 2011 and 2024, average publication date June 2019. Genes, ras, 1 publications between 2020 and 2020, average publication date July 2020. Leukemia, Lymphoid, 1 publications between 2020 and 2020, average publication date September 2020. Precursor Cells, B-Lymphoid, 1 publications between 2020 and 2020, average publication date September 2020. Bile Duct Neoplasms, 1 publications between 2024 and 2024, average publication date January 2024. Cholangiocarcinoma, 2 publications between 2024 and 2024, average publication date March 2024. Receptor, Fibroblast Growth Factor, Type 2, 2 publications between 2024 and 2024, average publication date March 2024.

To see the data from this visualization as text, click here.
Da Silva Silveira's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (194)
Explore
_
Co-Authors (14)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.